These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7190101)

  • 1. Antibodies against dehydration products of 15-keto-13,14-dihydro-prostaglandin E2.
    Peskar BM; Günter B; Steffens C; Kröner EE; Peskar BA
    FEBS Lett; 1980 Jun; 115(1):123-6. PubMed ID: 7190101
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of a radioimmunoassay for prostaglandin E2 metabolite levels in plasma.
    Demers LM; Brennecke SP; Mountford LA; Brunt JD; Turnbull AC
    J Clin Endocrinol Metab; 1983 Jul; 57(1):101-6. PubMed ID: 6853670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisera against 13,14-dihydro-15-keto-prostaglandin E2.
    Peskar BA; Holland A; Peskar BM
    FEBS Lett; 1974 Jul; 43(1):45-8. PubMed ID: 4859213
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13,14-dihydro-11 beta, 16 xi-cyclo-PGE2.
    Granström E; Fitzpatrick FA; Kindahl H
    Methods Enzymol; 1982; 86():306-20. PubMed ID: 7132761
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioimmunoassay for 13,14-dihydro,15-keto-prostaglandin E2 in human plasma: applications and artifacts.
    Metz SA; Rice MG; Robertson RP
    Adv Prostaglandin Thromboxane Res; 1980; 6():183-5. PubMed ID: 7386256
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastrointestinal ulcer formation in rabbits immunized with prostaglandin E2.
    Redfern JS; Blair AJ; Lee E; Feldman M
    Gastroenterology; 1987 Oct; 93(4):744-52. PubMed ID: 3114037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics.
    Bothwell W; Verburg M; Wynalda M; Daniels EG; Fitzpatrick FA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):229-35. PubMed ID: 6948952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of 13,14-dihydro-15-keto-PGE2 in some biological fluids as measured by radioimmunoassay.
    Levine L
    Prostaglandins; 1977; 14(6):1125-39. PubMed ID: 601248
    [No Abstract]   [Full Text] [Related]  

  • 9. Rat monoclonal antibody specific for prostaglandin E structure.
    Tanaka T; Ito S; Hiroshima O; Hayashi H; Hayaishi O
    Biochim Biophys Acta; 1985 Aug; 836(1):125-33. PubMed ID: 3927979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecificity of enzymatic reduction of prostaglandin E2 to F2alpha.
    Levine L; Wu KY; Pong SS
    Prostaglandins; 1975 Apr; 9(4):531-44. PubMed ID: 1153809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hapten mimic elicits antibodies recognizing prostaglandin E2.
    Fitzpatrick FA; Bundy GL
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2689-93. PubMed ID: 275836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of immune function and tumor growth inhibition by antibodies against prostaglandin E2.
    Young MR; Dizer M
    Immunol Commun; 1983; 12(1):11-23. PubMed ID: 6573300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of 13,14-dihydro-15-keto-PGF in biological fluids as measured by radioimmunoassay.
    Levine L; Gutierrez-Cernosek RM
    Prostaglandins; 1973 Jun; 3(6):785-804. PubMed ID: 4199676
    [No Abstract]   [Full Text] [Related]  

  • 14. Rat renal medulla possess high capacity to catabolize prostaglandins.
    Speziale E; Speziale N; Lugo S; Gimeno M
    Biochem Biophys Res Commun; 1984 Oct; 124(1):69-74. PubMed ID: 6437398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against prostaglandin E2: binding parameters.
    David F; Somme G; Provost-Wisner A; Theze J; Dray F
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():23-4. PubMed ID: 2936100
    [No Abstract]   [Full Text] [Related]  

  • 16. Instability of 13, 14-dihydro-15-keto-prostaglandin E2.
    Mitchell MD; Sors H; Flint AP
    Lancet; 1977 Sep; 2(8037):558. PubMed ID: 95757
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentrations of prostaglandin F2 alpha and prostaglandin E2 metabolites after transabdominal and transvaginal cervical cerclage.
    Novy MJ; Ducsay CA; Stanczyk FZ
    Am J Obstet Gynecol; 1987 Jun; 156(6):1543-52. PubMed ID: 3473937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radioimmunoassay for 13, 14-dihydro-15-keto prostaglandin F2alpha with chromatography and internal recovery standard.
    Haning RV; Kieliszek FX; Alberino SP; Speroff L
    Prostaglandins; 1977 Mar; 13(3):455-77. PubMed ID: 847245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisera to prostaglandins - production and characterization.
    Bauminger S
    J Immunol Methods; 1976; 13(3-4):253-9. PubMed ID: 1010939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13,14-dihydro-11 beta, 16-cyclo-PGE2.
    Granström E; Kindahl H
    Adv Prostaglandin Thromboxane Res; 1980; 6():181-2. PubMed ID: 7386255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.